Medical monitoring is crucial when taking semaglutide, as it allows healthcare providers to assess the patient's response to the medication and make necessary adjustments to the dosage, according to the NLM
The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed average weight reductions of approximately 15% of initial body weight over 68 weeks in individuals without diabetes, with somewhat lower reductions (about 9-10%) in those with type 2 diabetes
But as with any powerful medication, there can be some downside
Wegovy linked to rare eye stroke that can cause sudden blindness Researchers are sounding the alarm after Wegovy showed the strongest link yet to a rare eye stroke that can cause sudden blindness
Interestingly, new research published in the journal Nature Medicine evaluated the health outcomes of more than 2 million veterans with diabetes taking a GLP-1 and found that while the medications had positive effects on several health conditions, like heart disease and substance use disorders, they were negatively associated with some, including arthritis
At SOTA Wellness, treatment decisions are personalized around the patient, not the medication trend
